News
IIN
24.24
+0.04%
0.01
Short Volatility Alert: IntriCon Corporation
On Tuesday, shares of IntriCon Corporation (NASDAQ: IIN) experienced volatile short activity. After the activity, the stock price went up 0.4% to $24.24 The overall sentiment for IIN has been Bullish.
Benzinga · 05/25 14:22
TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?
TTDKY vs. IIN: Which Stock Is the Better Value Option?
Zacks · 03/28 15:40
Merger Arbitrage Mondays - Healthcare Trust Of America To Combine With Healthcare Realty Trust
Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced were potential deals in the works. Healthcare Trust of America (NYSE: HTA)
Benzinga · 03/07 15:33
Mid-Afternoon Market Update: Dow Drops Over 500 Points; Crude Oil Up 4.5%
U.S. stocks traded lower in another volatile session toward the end of trading on Monday, amid the ongoing Russia-Ukraine conflict, which has led to increased U.S. sanctions on Russia.
Benzinga · 02/28 19:44
Why Are Intricon Shares Surging Monday
Altaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN) for $24.25 per share in a transaction that values Intricon at an 
Benzinga · 02/28 18:20
42 Stocks Moving In Monday's Mid-Day Session
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development.
Benzinga · 02/28 17:43
Mid-Day Market Update: Nasdaq Turns Positive; Renewable Energy Group Shares Spike Higher
U.S. stocks pared some of its losses with the Nasdaq turning positive midway through trading on Monday, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia.
Benzinga · 02/28 17:39
EVBG, IRNT and NTRB among mid-day movers
Gainers: Mullen Automotive (NASDAQ:MULN) +126%. Renewable Energy Group (NASDAQ:REGI) +40%. IntriCon (NASDAQ:IIN) +37%. First Horizon (NYSE:FHN) +29%. Nordic American Tankers (NYSE:NAT) +27%. NeuroSense (NASDAQ:NRSN) +26%. CorMedix (NASDAQ:CRMD) +24%. Reata...
Seekingalpha · 02/28 17:37
Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict
U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia.
Benzinga · 02/28 15:38
--Colliers Securities Downgrades IntriCon to Neutral From Buy
MT Newswires · 02/28 15:11
IntriCon Corporation (IIN) Q4 Earnings and Revenues Surpass Estimates
IntriCon Corporation (IIN) delivered earnings and revenue surprises of 2,200% and 6.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 02/28 15:05
IntriCon, NeuroSense top healthcare gainers; Aurinia, Lexicon lead losers' pack
Gainers: IntriCon IIN +37%. NeuroSense Therapeutics (NASDAQ:NRSN) +28%. Homology Medicines FIXX +17%. CorMedix (NASDAQ:CRMD) +14%. Reata Pharmaceuticals (NASDAQ:RETA) +13%. Losers: Aurinia Pharmaceuticals AUPH -29%. Lexicon Pharmaceuticals LXRX -24%. Amryt...
Seekingalpha · 02/28 15:01
IntriCon to be acquired by Altaris Capital affiliate for $241M
Intricon (NASDAQ:IIN) has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry, will acquire the company. Under the
Seekingalpha · 02/28 14:01
IntriCon Non-GAAP EPS of $0.23, revenue of $32.2M
IntriCon press release (NASDAQ:IIN): Q4 Non-GAAP EPS of $0.23. Revenue of $32.2M (+6.3% Y/Y).
Seekingalpha · 02/28 13:49
BRIEF-Intricon Reports Fourth Quarter And Full Year 2021 Results
reuters.com · 02/28 13:44
IntriCon Q4 EPS $0.23 Down From $0.32 YoY, Sales $32.20M Up From $30.30M YoY
IntriCon (NASDAQ:IIN) reported quarterly earnings of $0.23 per share. This is a 28.13 percent decrease over earnings of $0.32 per share from the same period last year. The company reported $32.20 million in sales this
Benzinga · 02/28 13:42
Top Midday Gainers
MT Newswires · 02/28 13:38
Do Institutions Own IntriCon Corporation (NASDAQ:IIN) Shares?
Every investor in IntriCon Corporation ( NASDAQ:IIN ) should be aware of the most powerful shareholder groups...
Simply Wall St. · 02/28 11:20
Intricon Agrees to be Acquired by Altaris Capital Partners for $241 Million; Shares Surge Premarket
MT Newswires · 02/28 09:32
-- Earnings Flash (IIN) INTRICON CORPORATION Reports Q4 Revenue $32.2M
MT Newswires · 02/28 08:41
More
Webull provides a variety of real-time IIN stock news. You can receive the latest news about Intricon through multiple platforms. This information may help you make smarter investment decisions.
About IIN
Intricon Corporation is a joint development manufacturer (JDM) of micromedical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micromedical products for markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. The Company manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and body-worn devices for medical device manufacturers. It offers medical device manufacturers the capabilities to design, develop, manufacture, package and distribute medical devices. The Company has facilities in facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.